What are the odds? How common is it for people with MASH and advanced liver scarring to develop cirrhosis? Metabolic dysfunction-associated steatohepatitis (#MASH) is a progressive liver disease requiring timely detection and management. At Madrigal, the goal of our scientific program is to halt or reverse liver scarring before the devastating complications of cirrhosis occur. Stay tuned for the answer tomorrow!
This content isn’t available here
Access this content and more in the LinkedIn app